Fmr LLC lifted its stake in shares of Steris PLC (NYSE:STE) by 1.1% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 2,630,670 shares of the medical equipment provider’s stock after acquiring an additional 29,062 shares during the period. Fmr LLC owned 3.11% of Steris worth $300,948,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. Great West Life Assurance Co. Can increased its position in shares of Steris by 0.5% during the 2nd quarter. Great West Life Assurance Co. Can now owns 137,263 shares of the medical equipment provider’s stock worth $14,452,000 after purchasing an additional 697 shares during the last quarter. Sigma Investment Counselors Inc. acquired a new stake in shares of Steris during the 3rd quarter worth about $223,000. Northern Trust Corp increased its position in shares of Steris by 0.7% during the 2nd quarter. Northern Trust Corp now owns 643,608 shares of the medical equipment provider’s stock worth $67,585,000 after purchasing an additional 4,623 shares during the last quarter. Segall Bryant & Hamill LLC acquired a new stake in shares of Steris during the 2nd quarter worth about $557,000. Finally, Russell Investments Group Ltd. increased its position in shares of Steris by 16.1% during the 3rd quarter. Russell Investments Group Ltd. now owns 256,955 shares of the medical equipment provider’s stock worth $29,391,000 after purchasing an additional 35,561 shares during the last quarter. Institutional investors and hedge funds own 89.90% of the company’s stock.
In other news, insider Michael J. Tokich sold 34,500 shares of the business’s stock in a transaction dated Wednesday, November 7th. The stock was sold at an average price of $119.16, for a total transaction of $4,111,020.00. Following the completion of the transaction, the insider now directly owns 64,958 shares of the company’s stock, valued at $7,740,395.28. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Walter M. Rosebrough, Jr. sold 10,000 shares of the business’s stock in a transaction dated Wednesday, November 7th. The stock was sold at an average price of $120.50, for a total value of $1,205,000.00. The disclosure for this sale can be found here. Insiders own 2.38% of the company’s stock.
Several research firms have weighed in on STE. KeyCorp lifted their target price on Steris from $115.00 to $120.00 and gave the company an “overweight” rating in a research report on Thursday, August 9th. Stephens reaffirmed a “buy” rating and issued a $125.00 target price on shares of Steris in a research report on Thursday, August 9th. JMP Securities lifted their target price on Steris from $113.00 to $125.00 and gave the company a “market outperform” rating in a research report on Thursday, August 9th. Finally, Zacks Investment Research raised Steris from a “sell” rating to a “hold” rating in a research report on Thursday, September 20th. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. Steris presently has a consensus rating of “Buy” and an average price target of $119.33.
NYSE STE opened at $119.08 on Monday. The stock has a market capitalization of $10.06 billion, a price-to-earnings ratio of 28.69 and a beta of 1.03. The company has a debt-to-equity ratio of 0.41, a current ratio of 2.63 and a quick ratio of 2.01. Steris PLC has a 1-year low of $82.88 and a 1-year high of $121.67.
Steris (NYSE:STE) last released its earnings results on Tuesday, November 6th. The medical equipment provider reported $1.10 earnings per share for the quarter, beating the consensus estimate of $1.08 by $0.02. The company had revenue of $679.00 million during the quarter, compared to the consensus estimate of $659.14 million. Steris had a return on equity of 12.15% and a net margin of 11.72%. Steris’s revenue was up 7.1% compared to the same quarter last year. During the same period in the previous year, the company posted $0.94 EPS. On average, sell-side analysts forecast that Steris PLC will post 4.79 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Friday, December 21st. Shareholders of record on Wednesday, November 28th will be given a $0.34 dividend. This represents a $1.36 annualized dividend and a yield of 1.14%. The ex-dividend date of this dividend is Tuesday, November 27th. Steris’s dividend payout ratio is currently 32.77%.
STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.
Featured Article: How Do You Make Money With Penny Stocks?
Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Steris PLC (NYSE:STE).
Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.